Your browser doesn't support javascript.
loading
240-week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C.
Xu, Jing-Hang; Fan, Ya-Nan; Yu, Yan-Yan; Si, Chong-Wen; Zeng, Zheng; Xu, Zhong-Nan; Li, Jun; Mao, Qing; Zhang, Da-Zhi; Tang, Hong; Sheng, Ji-Fang; Chen, Xin-Yue; Ning, Qin; Shi, Guang-Feng; Xie, Qing; Zhang, Xi-Quan; Dai, Jun.
Afiliação
  • Xu JH; Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing, China.
  • Fan YN; Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing, China.
  • Yu YY; Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing, China.
  • Si CW; Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing, China.
  • Zeng Z; Department of Infectious Diseases, Center for Liver Diseases, Peking University First Hospital, Beijing, China.
  • Xu ZN; Jiangsu Chia-tai Tianqing Pharmaceutical Co, Ltd, Nanjing, China.
  • Li J; Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Mao Q; Department of Infectious Diseases, Southwest China Hospital, Chongqing, China.
  • Zhang DZ; Department of Infectious Diseases, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Tang H; Department of Infectious Diseases, West China Hospital, Chengdu, China.
  • Sheng JF; Department of Infectious Diseases, The First Affiliated Hospital of Zhejiang University, Hangzhou, China.
  • Chen XY; Department of International Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Ning Q; Department and Institute of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Shi GF; Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
  • Xie Q; Department of Infectious Diseases, Ruijin Hospital, Jiaotong University School of Medicine, Shanghai, China.
  • Zhang XQ; Jiangsu Chia-tai Tianqing Pharmaceutical Co, Ltd, Nanjing, China.
  • Dai J; Jiangsu Chia-tai Tianqing Pharmaceutical Co, Ltd, Nanjing, China.
J Viral Hepat ; 29(10): 862-867, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35737855
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite B Crônica Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Viral Hepat Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite B Crônica Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Viral Hepat Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido